Associations between cytokine gene variations and self-reported sleep disturbance in women following breast cancer surgery

Abstract Purpose of the research To attempt to replicate the associations found in our previous study of patients and family caregivers between interleukin 6 (IL6) and nuclear factor kappa beta 2 (NFKB2) and sleep disturbance and to identify additional genetic associations in a larger sample of pati...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of oncology nursing : the official journal of European Oncology Nursing Society Vol. 18; no. 1; pp. 85 - 93
Main Authors Alfaro, Emely, Dhruva, Anand, Langford, Dale J, Koetters, Theresa, Merriman, John D, West, Claudia, Dunn, Laura B, Paul, Steven M, Cooper, Bruce, Cataldo, Janine, Hamolsky, Deborah, Elboim, Charles, Kober, Kord, Aouizerat, Bradley E, Miaskowski, Christine
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.02.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Purpose of the research To attempt to replicate the associations found in our previous study of patients and family caregivers between interleukin 6 (IL6) and nuclear factor kappa beta 2 (NFKB2) and sleep disturbance and to identify additional genetic associations in a larger sample of patients with breast cancer. Methods and sample Patients with breast cancer ( n  = 398) were recruited prior to surgery and followed for six months. Patients completed a self-report measure of sleep disturbance and provided a blood sample for genomic analyses. Growth mixture modeling was used to identify distinct latent classes of patients with higher and lower levels of sleep disturbance. Key results Patients who were younger and who had higher comorbidity and lower functional status were more likely to be in the high sustained sleep disturbance class. Variations in three cytokine genes (i.e., IL1 receptor 2 (IL1R2), IL13, NFKB2) predicted latent class membership. Conclusions Polymorphisms in cytokine genes may partially explain inter-individual variability in sleep disturbance. Determination of high risk phenotypes and associated molecular markers may allow for earlier identification of patients at higher risk for developing sleep disturbance and lead to the development of more targeted clinical interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1462-3889
1532-2122
DOI:10.1016/j.ejon.2013.08.004